Dimethylamine → HCID 178483399, 화합물
반응식
[S:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[C:10]1[C:14]([CH2:15][CH2:16][CH2:17]Br)=[N:13][NH:12][C:11]=1[NH2:19].NC1NN=C(CCCO)C=1[C:30]1SC2C=CC=C[C:33]=2[N:34]=1.CNC.C1COCC1>>[S:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[C:10]1[C:14]([CH2:15][CH2:16][CH2:17][N:34]([CH3:33])[CH3:30])=[N:13][NH:12][C:11]=1[NH2:19]참가 물질
5
실험 절차
The title compound (100 mg) was prepared using 200 mg (0.59 mmol) of 4-benzothiazol-2-yl-5-(3-bromopropyl)-2H-pyrazol-3-ylamine, which was derived from 3-(5-amino-4-benzothiazol-2-yl-1H-pyrazol-3-yl)-propan-1-ol, and 5 mL of a 2 M solution of dimethylamine in THF (10 mmol). MS (m/z, ES+): 302.1 (M+1, 100%).
출처 및 근거
- ORD 기록
- ord-252ebdd432b148e2bc968db0acbaf849
- 출처 데이터셋
- uspto-grants-2010_12
- 특허 번호
- US07847101B2
반응 노트
불러오는 중…